Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

334
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
334
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Early Versus Late(r) Administration of Intrapleural Fibrinolytic Therapy in Children with Empyema: A Systematic Review and Meta-Analysis.

Indian pediatrics·2026
Same author

Thoracic Computed Tomography Scan Versus Thoracic Ultrasonography for Management Decisions in Empyema Thoracis: A Systematic Review.

Indian pediatrics·2026
Same author

Clinical Profile of Cystic Fibrosis in India: A Multi-Centric Prospective Study.

Journal of paediatrics and child health·2026
Same author

Clinical Signs of Circulatory Impairment/Shock in Children: A Prospective Observational Study.

Indian journal of pediatrics·2026
Same author

Factors associated with pulmonary TB in malnourished children admitted to rehabilitation centres.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2026
Same author

Profile of cystic fibrosis transmembrane conductance regulator (CFTR) gene variants across India and their variability in different geographic regions.

Gene·2025

相关实验视频

Updated: Jul 8, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K

结核病预防治疗 预防性治疗

Anshula Tayal1, S K Kabra2

  • 1Department of Pediatrics, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Indian journal of pediatrics
|December 14, 2023
PubMed
概括

结核病预防治疗 (TPT) 旨在防止潜伏结核病感染 (LTBI) 进展为活跃疾病. 目前的TPT疗法包括每天6个月的伊索尼亚齐德 (6H) 和每周3个月的伊索尼亚齐德/里法丁疗法 (3HP).

科学领域:

  • 传染性疾病 传染性疾病
  • 公共卫生 公共卫生
  • 微生物学 微生物学

背景情况:

  • 暴露于Mycobacterium结核病可能导致潜伏结核病感染 (TBI),构成活跃疾病的终身风险.
  • 结核病预防性治疗 (TPT) 对于管理TBI和防止进展到活跃结核病 (TB) 至关重要.
  • 诊断TBI间接依赖于基于免疫的测试,如结核素皮肤测试 (TST) 和干扰素-释放试验 (IGRA),因为微生物学确认尚未可能.

研究的目的:

  • 审查结核病预防治疗 (TPT) 方案的演变和现状.
  • 强调在启动 TPT 之前排除活跃结核病的重要性.
  • 讨论针对耐药结核病 (DR-TB) 病例接触者的定制TPT策略以及监测的必要性.

主要方法:

  • 审查现有的TPT疗法,包括每日6个月的伊索尼亚齐德 (6H) 和新兴的每周3个月的伊索尼亚齐德和利法丁 (3HP) 疗法.
  • 讨论使用基于免疫的测试 (TST,IGRAs) 的TBI诊断方法.
  • 考虑对DR-TB患者的接触者进行TPT,强调抗药性结核病模式分析和细菌学确认.

主要成果:

  • 6H疗法被广泛使用,而3HP是2岁以上个体的新兴选择.
  • 在开始TPT之前必须排除活性结核病,以确保安全性和有效性.
关键词:
潜在的结核病感染.结核病感染 结核病感染结核病预防治疗 预防性治疗

更多相关视频

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

相关实验视频

Last Updated: Jul 8, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.8K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K
  • 对于DR-TB接触器的TPT,需要根据索引案例的电阻概况制定特定的方案.
  • 结论:

    • 通过治疗潜伏感染和预防疾病进展,TPT是对抗结核病的重要策略.
    • 密切监测TPT患者至关重要,以便及时检测出任何活跃结核病的迹象.
    • 在TPT疗法和针对特定人群的量身定制方法,如DR-TB接触者的进步,对于结核病控制工作至关重要.